Academic Journal
Canakinumab for Treatment of Adult-Onset Still's Disease to Achieve Reduction of Arthritic Manifestation (CONSIDER): phase II, randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial
| العنوان: | Canakinumab for Treatment of Adult-Onset Still's Disease to Achieve Reduction of Arthritic Manifestation (CONSIDER): phase II, randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial |
|---|---|
| المؤلفون: | Kedor, Claudia, Listing, Joachim, Zernicke, Jan, Weiß, Anja, Behrens, Frank, Blank, Norbert, Henes, Joerg Christoph, Kekow, Joern, Rubbert-Roth, Andrea, Schulze-Koops, Hendrik, Seipelt, Eva, Specker, Christof, Feist, Eugen |
| المساهمون: | Novartis Pharma GmbH |
| المصدر: | Annals of the Rheumatic Diseases ; volume 79, issue 8, page 1090-1097 ; ISSN 0003-4967 |
| بيانات النشر: | Elsevier BV |
| سنة النشر: | 2020 |
| المجموعة: | ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| DOI: | 10.1136/annrheumdis-2020-217155 |
| الاتاحة: | https://doi.org/10.1136/annrheumdis-2020-217155 https://api.elsevier.com/content/article/PII:S0003496724012937?httpAccept=text/xml https://api.elsevier.com/content/article/PII:S0003496724012937?httpAccept=text/plain https://syndication.highwire.org/content/doi/10.1136/annrheumdis-2020-217155 |
| Rights: | https://www.elsevier.com/tdm/userlicense/1.0/ ; https://www.elsevier.com/legal/tdmrep-license |
| رقم الانضمام: | edsbas.4E5DB6F2 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1136/annrheumdis-2020-217155 |
|---|